HY-B0493-100mg
|
MedChemexpress LLC
|
Niflumic acid [CAS 4394-00-7]
|
|
COVID-19-immunoregulation
|
|
HY-B0493-1mL
|
MedChemexpress LLC
|
Niflumic acid [CAS 4394-00-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-150204-10mg
|
MedChemexpress LLC
|
ONO-0740556 [CAS 2250210-69-4]
|
|
COVID-19-immunoregulation
|
|
HY-150204-25mg
|
MedChemexpress LLC
|
ONO-0740556 [CAS 2250210-69-4]
|
|
COVID-19-immunoregulation
|
|
HY-150204-5mg
|
MedChemexpress LLC
|
ONO-0740556 [CAS 2250210-69-4]
|
|
COVID-19-immunoregulation
|
|
HY-150204-50mg
|
MedChemexpress LLC
|
ONO-0740556 [CAS 2250210-69-4]
|
|
COVID-19-immunoregulation
|
|
HY-W008613-1g
|
MedChemexpress LLC
|
Pamoic acid [CAS 130-85-8]
|
|
COVID-19-immunoregulation
|
|
HY-112706-10mg
|
MedChemexpress LLC
|
PF-06747711 [CAS 1892576-58-7]
|
|
COVID-19-immunoregulation
|
|
HY-112706-100mg
|
MedChemexpress LLC
|
PF-06747711 [CAS 1892576-58-7]
|
|
COVID-19-immunoregulation
|
|
HY-112706-5mg
|
MedChemexpress LLC
|
PF-06747711 [CAS 1892576-58-7]
|
|
COVID-19-immunoregulation
|
|
HY-112706-50mg
|
MedChemexpress LLC
|
PF-06747711 [CAS 1892576-58-7]
|
|
COVID-19-immunoregulation
|
|
HY-112706-1mL
|
MedChemexpress LLC
|
PF-06747711 [CAS 1892576-58-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-145384-10mg
|
MedChemexpress LLC
|
ROC-0929 [CAS 1048660-43-0]
|
|
COVID-19-immunoregulation
|
|
HY-145384-100mg
|
MedChemexpress LLC
|
ROC-0929 [CAS 1048660-43-0]
|
|
COVID-19-immunoregulation
|
|
HY-145384-25mg
|
MedChemexpress LLC
|
ROC-0929 [CAS 1048660-43-0]
|
|
COVID-19-immunoregulation
|
|
HY-145384-5mg
|
MedChemexpress LLC
|
ROC-0929 [CAS 1048660-43-0]
|
|
COVID-19-immunoregulation
|
|
HY-145384-50mg
|
MedChemexpress LLC
|
ROC-0929 [CAS 1048660-43-0]
|
|
COVID-19-immunoregulation
|
|
HY-133552-1mg
|
MedChemexpress LLC
|
RORgammat Inverse agonist 10 [CAS 2413986-35-1]
|
|
COVID-19-immunoregulation
|
|
HY-133552-10mg
|
MedChemexpress LLC
|
RORgammat Inverse agonist 10 [CAS 2413986-35-1]
|
|
COVID-19-immunoregulation
|
|
HY-133552-100mg
|
MedChemexpress LLC
|
RORgammat Inverse agonist 10 [CAS 2413986-35-1]
|
|
COVID-19-immunoregulation
|
|